Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits CaV1.2, CaV1.3 and CaV3.1

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 263-267

  Tanaka, Hikaru ^a   Namekata, Iyuki ^a   Ogawa, Toru ^a   Tsuneoka, Yayoi ^a   Komikado, Chisa ^a   Takahara, Akira ^a   Iida Tanaka, Naoko ^a,b   Izumi Nakaseko, Hiroko ^c   Tsuru, Hiromichi ^c   Adachi Akahane, Satomi ^c  

^a TOHO UNIVERSITY   (Japan)

^b OTSUMA WOMEN'S UNIVERSITY   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CaV1.3; Calcium channel; S(+) efonidipine; Sinus node

Indexed keywords

CALCIUM CHANNEL CAV1.2 ALPHA SUBUNIT; CALCIUM CHANNEL CAV1.3 ALPHA SUBUNIT; CALCIUM CHANNEL CAV3.1 ALPHA SUBUNIT; EFONIDIPINE; NIFEDIPINE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENANTIOMER; EXPERIMENTAL RABBIT; HEART DEPOLARIZATION; INHIBITION KINETICS; ION CURRENT; MALE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACEMIC MIXTURE; SINUS NODE MEMBRANE POTENTIAL;

ACTION POTENTIALS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL LINE; CRICETINAE; DEPRESSION, CHEMICAL; DIHYDROPYRIDINES; HEART RATE; ISOMERISM; KINETICS; MALE; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; PATCH-CLAMP TECHNIQUES; PROTEIN ISOFORMS; PROTEIN SUBUNITS; RABBITS; RECOMBINANT PROTEINS; SINOATRIAL NODE;

EID: 78049266302     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.014     Document Type: Article

References (22)

1. 2+ channels. Br. J. Pharmacol. 2004, 143:1050-1057.
2. Klugbauer N., Marais E., Lacinova L., Hofmann F. A T-type calcium channel from mouse brain. Pflugers Arch. Eur. J. Physiol. 1999, 437:710-715.
3. 2+ channels activating at negative voltages. J Biol Chem 2001, 276:22100-22106.
4. 2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. USA 2003, 100:5543-5548.
5. Masuda Y., Tanaka S. Efonidipine hydrochloride: a new calcium antagonist. Cardiovasc. Drug Rev. 1994, 12:123-135.
6. Masuda Y., Miyajima M., Shudo C., Tanaka S., Shigenobu K., Kasuya Y. Cardiovascular selectivity of 1, 4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues. Gen. Pharmacol. 1995, 26:339-345.
7. 2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine. Eur. J. Pharmacol. 1997, 335:15-21.
8. 2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur. J. Pharmacol. 1998, 349:351-357.
9. Morimoto S., Jo T., Maki K., Iwasaka T. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress. Clin. Exp. Hypertens. 2009, 31:83-91.
10. Ohashi N., Mitamura H., Ogawa S. Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodeling during atrial fibrillation. Drugs 2009, 69:21-30.
11. 2+ current in guinea-pig heart. Br. J. Pharmacol. 1994, 113:451-456.
12. Ono K., Iijima T. Ionic and molecular basis of cardiac automaticity in mammalian heart. Molecular mechanisms of heart diseases 2005, 1-22. Research SignPost, Trivandrum. Y. Mizukami, T. Ohtsuka (Eds.).
13. 2+ channels. Cell 2000, 102:89-97.
14. 2+ channel blocking action, on heart rate. Ther. Res. 2001, 22:883-889.
15. 2+ channels. Cardiovasc. Drug Rev. 2002, 20:81-92.
16. 2+ channels and drug development. J. Pharmacol. Sci. 2005, 99:214-220.
17. Tanaka H., Masumiya H., Sekine T., Shijuku T., Sugahara M., Taniguchi H., Terada M., Saito W., Shigenobu K. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem. Gen. Pharmacol. 1996, 27:451-454.
18. Tanaka H., Komikado C., Shimada H., Takeda K., Namekata I., Kawanishi T., Shigenobu K. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium. J. Pharmacol. Sci. 2004, 96:499-501.
19. Tanaka H., Komikado C., Namekata I., Nakamura H., Suzuki M., Tsuneoka Y., Shigenobu K., Takahara A. Species difference in the contribution of T-type calcium current to cardiac pacemaking as revealed by R(-)-efonidipine. J. Pharmacol. Sci. 2008, 107:99-102.
20. Tanaka T., Tsutamoto T., Sakai H., Fujii M., Yamamoto T., Horie M. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens. Res. 2007, 30:691-697.
21. 2+ channel agonists. J. Biol. Chem. 2000, 275:41504-41511.
22. D) calcium channel in sinoatrial nodes. Insight gained using gene-targeted null mutant mice. Circ. Res. 2002, 90:981-987.